December 8, 2022
FDA: Class I recall of Dewei Medical Equipment’s DNA/RNA Preservation Kits
Editor's Note
The Food and Drug Administration (FDA) on December 8 identified the recall by Dewei Medical Equipment Co of its DNA/RNA Preservation Kits as Class I, the most serious.
The kits are used to collect, preserve, and transport clinical samples that will be tested for viruses, including COVID-19.
The recall was initiated because the kits were distributed to US customers without authorization, clearance, or approval by the FDA.
Distribution dates were May 2020 to January 2022.
Free Daily News
- Tenet, HCA post strong Q1 results, but caution looms over policy uncertainty, outpatient trends
- Telemedicine transforms postoperative care through safer, faster, patient-centered recovery
- ASCA conference coverage keeps ASC leaders informed
- Study: Prolonged COVID symptoms more likely for healthcare workers
- Study: Patients of female surgeons experience fewer complications, lower long-term readmission
- OR traffic, workflow disruptions drive infection risk
- Proactive strategies help healthcare supply chains withstand tariff pressures
- Study: EEG-guided anesthesia halves anesthetic use, accelerates recovery in pediatric surgery
- Study: Longer shifts, understaffing increase nurse sickness absence
- Power loss risks prompt FDA Class 1 recall designation for heart pump accessories
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement